In toxicology, we mainly cover 2 distinct areas which are:
-The research and quantification of alcohol and narcotic products (road checks, forensic medicine, occupational medicine, addictology monitoring, pre-transplant assessment)
-Biometrology, namely the biological determination of the level of exposure to heavy metals and other solvents in a professional context.
We offer four panels (drugs and associated metabolites) for the quantification of narcotics, as well as a panel of alcohols and, more recently, the determination of alcohol impregnation levels via the quantification of a direct ethanol metabolite, phosphatidylethanol.
In biometrology, we work closely with the occupational medicine departments in many different companies. Our international presence enables us to support a number of companies in their efforts, especially in the mining sector, which is highly exposed to numerous toxic substances.
Our activity is regularly used to support regional health authorities in their efforts to deal with the consequences of sometimes dramatic events, such as flooding in the Orbiel valley and a subsequent exposure to arsenic, or the fire at Notre-Dame cathedral in Paris causing potential lead exposure for children in the surrounding schools, or an exposure to Chlordecone in French oversea territories and regions concerning professionals and local populations (Martinique and Guadeloupe).
We offer a solution for quantifying exposure to phthalates and bisphenols. These molecules are toxic endocrine disruptors, to which we are all exposed to a greater or lesser extent, and which have been the subject of significant regulatory changes over the last 10 years.
The most sensitive populations are children, especially under the age of 3 and also up to adolescence. Women planning pregnancy and pregnant women are also directly concerned.
We are now in a position to understand this exposure, however variable and fluctuating it may be, and targeted preventive measures can be recommended by our experts, thus promoting an effective reduction in exposure to these endocrine disruptors.
